Literature DB >> 8605891

Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations.

S J Delaney1, E W Alton, S N Smith, D P Lunn, R Farley, P K Lovelock, S A Thomson, D A Hume, D Lamb, D J Porteous, J R Dorin, B J Wainwright.   

Abstract

We have generated a mouse carrying the human G551D mutation in the cystic fibrosis transmembrane conductance regulator gene (CFTR) by a one-step gene targeting procedure. These mutant mice show cystic fibrosis pathology but have a reduced risk of fatal intestinal blockage compared with 'null' mutants, in keeping with the reduced incidence of meconium ileus in G551D patients. The G551D mutant mice show greatly reduced CFTR-related chloride transport, displaying activity intermediate between that of cftr(mlUNC) replacement ('null') and cftr(mlHGU) insertional (residual activity) mutants and equivalent to approximately 4% of wild-type CFTR activity. The long-term survival of these animals should provide an excellent model with which to study cystic fibrosis, and they illustrate the value of mouse models carrying relevant mutations for examining genotype-phenotype correlations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605891      PMCID: PMC449990     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

Review 1.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Authors:  M J Welsh; A E Smith
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

2.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

Authors:  M L Drumm; D J Wilkinson; L S Smit; R T Worrell; T V Strong; R A Frizzell; D C Dawson; F S Collins
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

3.  Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice.

Authors:  E W Alton; P G Middleton; N J Caplen; S N Smith; D M Steel; F M Munkonge; P K Jeffery; D M Geddes; S L Hart; R Williamson
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

4.  Cystic fibrosis in the mouse by targeted insertional mutagenesis.

Authors:  J R Dorin; P Dickinson; E W Alton; S N Smith; D M Geddes; B J Stevenson; W L Kimber; S Fleming; A R Clarke; M L Hooper
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

5.  Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR.

Authors:  Y Yang; D C Devor; J F Engelhardt; S A Ernst; T V Strong; F S Collins; J A Cohn; R A Frizzell; J M Wilson
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

6.  Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels.

Authors:  S J Delaney; D P Rich; S A Thomson; M R Hargrave; P K Lovelock; M J Welsh; B J Wainwright
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium.

Authors:  J H Widdicombe; M J Welsh; W E Finkbeiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.

Authors:  A Hamosh; T M King; B J Rosenstein; M Corey; H Levison; P Durie; L C Tsui; I McIntosh; M Keston; D J Brock
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

9.  Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR.

Authors:  L Zhou; C R Dey; S E Wert; M D DuVall; R A Frizzell; J A Whitsett
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

10.  Phosphatase inhibitors activate normal and defective CFTR chloride channels.

Authors:  F Becq; T J Jensen; X B Chang; A Savoia; J M Rommens; L C Tsui; M Buchwald; J R Riordan; J W Hanrahan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more
  36 in total

1.  Cystic fibrosis presenting with corneal perforation and crystalline lens extrusion.

Authors:  Danielle S Hall; Saurabh Goyal
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

2.  Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.

Authors:  G B Pier; M Grout; T S Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Characterisation of chloride currents across the proximal colon in CftrTgH(neoim)1Hgu congenic mice.

Authors:  E-M Bleich; S Leonhard-Marek; M Beyerbach; G Breves
Journal:  J Comp Physiol B       Date:  2006-07-26       Impact factor: 2.200

4.  Generation of a conditional null allele for Cftr in mice.

Authors:  Craig A Hodges; Calvin U Cotton; Mark R Palmert; Mitchell L Drumm
Journal:  Genesis       Date:  2008-10       Impact factor: 2.487

5.  Scnn1b-Transgenic BALB/c Mice as a Model of Pseudomonas aeruginosa Infections of the Cystic Fibrosis Lung.

Authors:  Kristen J Brao; Brendan P Wille; Joshua Lieberman; Robert K Ernst; Mark E Shirtliff; Janette M Harro
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

6.  Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.

Authors:  Folke Freudenberg; Monika R Leonard; Shou-An Liu; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

7.  Enhancing the efficiency of introducing precise mutations into the mouse genome by hit and run gene targeting.

Authors:  P Dickinson; W L Kimber; F M Kilanowski; S Webb; B J Stevenson; D J Porteous; J R Dorin
Journal:  Transgenic Res       Date:  2000-02       Impact factor: 2.788

Review 8.  Animal models for cystic fibrosis liver disease (CFLD).

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Massimiliano Cadamuro; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-07-30       Impact factor: 5.187

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

10.  Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages.

Authors:  Ludmila V Deriy; Erwin A Gomez; Guangping Zhang; Daniel W Beacham; Jessika A Hopson; Alexander J Gallan; Pavel D Shevchenko; Vytautas P Bindokas; Deborah J Nelson
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.